CDC advisory committee unanimously recommends Pfizer’s pediatric COVID-19 vaccine
The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices today recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11. The 14-0 vote paves the way for the first doses to be administered to that age group, pending approval by CDC Director Rochelle Walensky, M.D. Across its deliberations, the committee urged thorough, clear communications with families of potential-but-rare side effects, including myocarditis, with information on symptoms and where to seek medical care.
Related News Articles
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…